Matinas BioPharma gets NYSE American non-compliance notice
Matinas BioPharma Holdings said it received a notice on Aug. 31, 2026 from NYSE American LLC stating it is not in compliance with continued listing standards.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Matinas BioPharma gets NYSE American notice of noncompliance
On Aug. 31, 2026, Matinas BioPharma received a NYSE American notice of noncompliance with Section 1003(a)(i). The exchange cited stockholders’ equity of $1.8 million versus a $2.0 million minimum and losses in recent years.